Clinical Decision-Making Differences Between Primary Care Physicians Using and Not Using Cancer Risk Assessment Questionnaires
DOI:
https://doi.org/10.32782/2077-6594/2026.3/24Keywords:
primary care, physician, clinical decision-making, risk factors, questionnaire, screeningAbstract
Clinical decision-making by primary care physicians is essential for early cancer detection. Structured tools for assessing cancer risk factors, including patient questionnaires, may promote systematic history taking, improve identification of warning symptoms and risk factors, and increase cancer awareness. Such tools may also support clinical reasoning and timely referral for diagnostic and screening procedures within routine primary care clinical practice settings. Purpose is to assess differences in clinical approaches and decision-making among primary care physicians depending on whether they use patient questionnaires to identify cancer risk factors. Materials and Methods. A cross-sectional analytical study involved 311 general practitioners – family physicians. Respondents were divided into two groups: physicians who did not use questionnaires to assess cancer risk factors (n=75) and physicians who used them in clinical practice (n=236). The questionnaire included sociodemographic and professional characteristics, clinical symptoms, cancer risk factors, and prescription of screening and diagnostic examinations. Statistical analysis was performed using MedCalc® Statistical Software, version 22.009. Categorical variables were compared using the χ² test or Fisher’s exact test when expected frequencies were small. Statistical significance was set at p<0.05. Results. Questionnaire use was significantly associated with physicians’ length of professional experience (p=0.007). Among physicians who used questionnaires, 42.4% had more than 20 years of professional experience compared with 21.3% among those who did not. Practice location (p=0.621) and number of patient declarations (p=0.219) were not significantly associated with questionnaire use. Physicians who used questionnaires more frequently considered gastrointestinal disturbances (67.4% vs 48.0%; p=0.004) and urinary disturbances (65.3% vs 48.0%; p=0.010) as clinically relevant. A positive family history of cancer was also more frequently taken into account by questionnaire users (90.3% vs 77.3%; p=0.006). No statistically significant differences were found for unexplained weight loss, fatigue, palpable mass, pain of unclear origin, prolonged stress, overweight, hazardous occupational conditions, low physical activity, smoking, alcohol consumption, or excessive red meat intake. Domestic or sexual violence was more frequently identified among questionnaire users, although the difference was not statistically significant (12.7% vs 5.3%; p=0.089). Questionnaire use was also associated with selected diagnostic decisions. Physicians who used questionnaires more often prescribed faecal occult blood testing (68.6% vs 54.7%; p=0.036) and tumour marker testing (26.7% vs 14.7%; p=0.042). No statistically significant differences were observed for mammography, colonoscopy, ultrasound examinations, or prostate-specific antigen testing for prostate cancer. Professional or emotional exhaustion (p=0.196), working in one versus several healthcare facilities (p=0.236), and job satisfaction (p=0.124) were not associated with questionnaire use. Overall, questionnaire use was linked to a more structured approach to cancer risk assessment, greater attention to selected clinical manifestations and family history, and certain diagnostic decisions in primary care. This may facilitate earlier identification of patients at increased cancer risk and support timely diagnostic pathways. Conclusions. The use of questionnaires for assessing cancer risk factors is associated with a more systematic approach to medical history taking, evaluation of selected clinical symptoms, identification of family cancer history, and prescription of certain diagnostic tests. Structured cancer risk assessment tools may support clinical decision-making and improve early identification of patients requiring further diagnostic evaluation.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. DOI: 10.3322/caac.21660.
Barclay ME, Abel GA, Greenberg DC, Rous B, Lyratzopoulos G. Socio-demographic variation in stage at diagnosis of breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, renal and ovarian cancer in England and its population impact. Br J Cancer. 2021;124(7):1320–9. DOI: 10.1038/s41416-021-01279-z.
Willis TA, Neal RD, Walter FM, Foy R. Priorities for implementation research on diagnosing cancer in primary care: a consensus process. BMC Health Serv Res. 2023;23(1):1308. DOI: 10.1186/s12913-023-10330-z.
Smith CF, Drew S, Ziebland S, Nicholson BD. Understanding the role of GPs’ gut feelings in diagnosing cancer in primary care. Br J Gen Pract. 2020;70(698):e612–21. DOI: 10.3399/bjgp20X712301.
Medina-Lara A, Grigore B, Lewis R, Peters J, Price S, Landa P, et al. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis. Health Technol Assess. 2020;24(66):1–332. DOI: 10.3310/hta24660.
Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;3:17. DOI: 10.1038/s41746-020-0221-y.
Власик ЛЙ. Досвід пацієнта та його роль у медичній активності на прикладі економічно активного населення. Вісник соціальної гігієни та організації охорони здоров’я України. 2020;(3):89–96. DOI: 10.11603/1681-2786.2020.3.11628.
Таранов ВВ, Теренда НО. Стан та проблеми сучасної онкології (за даними огляду літератури). Україна. Здоров’я нації. 2023;(3):154–9. DOI: 10.32782/2077-6594/2023.3/26.
Зуб ВО, Котуза АС. Аналіз надання допомоги пацієнтам з онкологічними захворюваннями в умовах воєнного стану. Вісник соціальної гігієни та організації охорони здоров’я України. 2022;(3):35–40. DOI: 10.11603/1681-2786.2022.3.13434.
Bradley PT, Hall N, Maniatopoulos G, Neal RD, Paleri V, Wilkes S. Factors shaping the implementation and use of Clinical Cancer Decision Tools by GPs in primary care: a qualitative framework synthesis. BMJ Open. 2021;11(2):e043338. DOI: 10.1136/bmjopen-2020-043338.
Oliva-Fanlo B, March S, Medina D, Martín-Rabadán M, Tamborero G, Stolper E, et al. Prevalence and diagnostic value of GPs’ gut feelings for cancer and serious diseases: protocol for a prospective observational study of diagnostic validity. BMJ Open. 2019;9(10):e032404. DOI: 10.1136/bmjopen-2019-032404.
Hardy V, Yue A, Archer S, Merriel SWD, Thompson M, Emery J, et al. Role of primary care physician factors on diagnostic testing and referral decisions for symptoms of possible cancer: a systematic review. BMJ Open. 2022;12(1):e053732. DOI: 10.1136/bmjopen-2021-053732.
Машкевич ОГ, Вежновець ТА. Особливості організації раннього виявлення злоякісних новоутворень у жителів міст та сільської місцевості на рівні первинної медичної допомоги. Вісник соціальної гігієни та організації охорони здоров’я України. 2025;4(106):80–6. DOI: 10.11603/1681-2786.2025.4.15901.
Міністерство охорони здоров’я України. Про затвердження Уніфікованого клінічного протоколу первинної та спеціалізованої медичної допомоги «Базальноклітинний рак шкіри»: наказ МОЗ України від 14 березня 2024 р. № 436 [Internet]. Київ: МОЗ України; 2024. Доступно: https://moz.gov.ua/uk/decrees/nakaz-moz-ukraini-vid-14032024--436-pro-zatverdzhennjaunifikovanogo--klinichnogo-protokolu-pervinnoi--ta-specializovanoi-medichnoi--dopomogi-bazalnoklitinnij-rak-shkir.




